Cardiac inotropic actions of urocortin in conscious sheep

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 5 41-5, 1997, Pages

  Parkes, David G ^a,c   Vaughan, Joan ^b   Rivier, Jean ^b   Vale, Wylie ^b   May, Clive N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

adrenocorticotropin; blood pressure; cardiac contractility; corticotropin releasing factor

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; PEPTIDE HORMONE;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE; HORMONE ACTION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; SHEEP;

EID: 0030924922     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.5.h2115     Document Type: Article

References (14)

1. Bednarik, J., and C. May. Evaluation of a transit-time system for the chronic measurement of regional blood flow in conscious sheep. J. Appl. Physiol. 78: 524-530, 1994.
2. Bednarik, J., and C. May. Differential regional hemodynamic effects of corticotropin in conscious sheep. Hypertension 24: 49-55, 1994.
3. Brown, M., and L. Fisher. Central nervous system effects of corticotropin-releasing factor in the dog. Brain. Res. 280: 75-79, 1983.
4. Chadwick, D., J. Marsh, J. Ackryl (Editors). Corticotropin-Releasing Factor. Chichester, UK: Wiley, 1993.
5. Donaldson, C., S. Sutton, M. Perrin, A. Corrigan, K. Lewis, J. Rivier, J. Vaughan, and W. Vale. Cloning and characterization of human urocortin. Endocrinology 137: 2167-2170, 1996.
6. Fei, D., W. Graham, J. McDougall, and J. Coghlan. [Des-Asp1]-angiotensin II in the sheep: blood levels and its effect on plasma renin concentration. Life Sci. 27: 1495-1502, 1980.
7. Fisher, L., C. Rivier, J. Rivier, and M. Brown. Differential antagonist activity of alpha-helical corticotropin-releasing factor antagonist 9-41 in three bioassay systems. Endocrinology 129: 1312-1316, 1991.
8. Fisher, L. A., and M. R. Brown. Corticotropin-releasing factor and angiotensin II: comparison of CNS actions to influence neuroendocrine and cardiovascular function. Brain Res. 296: 41-47, 1984.
9. Grosskreutz, C., and M. Brody. Regional hemodynamic responses to central administration of corticotropin-releasing factor (CRF). Brain Res. 442: 363-367, 1988.
10. Grunt, M., J. Glaser, H. Schmidhuber, P. Pauschinger, and J. Born. Effects of corticotropin-releasing factor on isolated rat heart activity. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1124-H1129, 1993.
11. Heldwein, K., D. Redick, M. Rittenberg, W. Claycomb, and M. Stenzel-Poore. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells. Endocrinology 137: 3631-3639, 1996.
12. Hermus, A., G. Pieters, J. Willemsen, H. Ross, A. Smals, T. Benrad, and P. Kloppenberg. Hypotensive effects of ovine and human corticotrophin-releasing factor in man. Eur. J. Clin. Pharmacol. 31: 531-534, 1987.
13. Kalin, N., J. Gonder, and S. Shelton. Effects of synthetic ovine CRF on ACTH, cortisol and blood pressure in sheep. Peptides 4: 221-223, 1983.
14. Kishimoto, T., R. Pearse, C. Lin, and M. Rosenfeld. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 92: 1108-1112, 1995.